Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VALSARTAN DISODIUM, with a corresponding US DMF Number 33427.
Remarkably, this DMF maintains an Active status since its submission on March 15, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 05, 2019, and payment made on February 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II